In addition to flu vaccines for the general public and RSV vaccines for older adults and pregnant people, new COVID vaccines from Pfizer-BioNTech, Moderna and Novavax are available this season to ...

Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and stand-alone flu inoculation, sending shares down sharply. The vaccine ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the European Commission granted Marketing Authorization for ...

How is Novavax’s vaccine different from mRNA vaccines? Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus that their body ...

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined Covid-flu vaccine and standalone flu inoculation due to safety concerns.

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...

Novavax Inc (NASDAQ:NVAX) shares are bouncing around Wednesday, pulling back after popping in early trading. The company announced that it received European marketing authorization for its ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

(Bloomberg) -- Novavax Inc. shares fell as much as 24% after US regulators placed a hold on the company’s experimental influenza and Covid-19 combination vaccines because a study volunteer ...

Novavax (NVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mayank Mamtani from B.Riley Financial reiterated a Buy rating on the stock ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica is a writer on the Wellness team with a focus on health ...